ArticleBMC gastroenterology2025
Low preoperative serum creatinine levels are associated with poor prognosis in patients with hepatocellular carcinoma after liver resection: a multicenter study.
Article in BMC gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundPrevious studies have typically focused on the effect of high preoperative serum creatinine (SCr) levels on the prognosis of hepatocellular carcinoma (HCC) patients but have often ignored the role of low SCr levels. This study aimed to assess the impact of low SCr levels on HCC patient prognosis.
methods3857 patients who underwent primary liver resection from seven centers were divided into low, normal and high SCr groups according to their baseline SCr levels. Factors independently associated with textbook outcome (TO) and overall survival (OS) were analyzed. Propensity score matching (PSM) was used to balance the baseline characteristics between the low- and normal-SCr groups, as well as between the high- and normal-SCr groups.
resultsTO was observed in 2403 (62.3%) patients. The TO rate in the normal SCr group was 63.4%, which was significantly higher than that in the low (48.5%, P < 0.001) and high (53.3%, P = 0.017) SCr groups in the whole cohort. Multivariate analysis confirmed that both low and high SCr levels independently contributed to non-TO achievement. The 5-year OS was 67.6% for the normal SCr group, which was significantly better than that of the low SCr group (51.1%, P < 0.001) but similar to that of the high SCr group (66.4%, P = 0.697) in the whole cohort. Similar results were observed after PSM. Multivariate analysis suggested that a low SCr level (HR = 1.328, 95% CI = 1.076–1.639, P = 0.008) was independently associated with OS, whereas a high SCr level (HR = 1.173, 95% CI = 0.870–1.583, P = 0.294) was not.
conclusionsLow SCr levels could affect both TO achievement and OS in HCC patients after liver resection. A low SCr level offers useful information for preoperative risk stratification, optimizes perioperative care and improves the prognosis of HCC patients. We should not ignore the effect of low preoperative SCr levels on HCC patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.